EPISODE · Nov 14, 2015 · 4 MIN
Clinical Trial Spotlight: Should a Second Generation ALK Inhibitor be First Line Therapy for Patients with ALK-Positive NSCLC?
from GRACEcast · host cancerGRACE Meetings
Dr. Jack West asks the question of whether newer, more active ALK inhibitors such as alectinib should be used as first line therapy rather than for acquired resistance, including introducing the ALEX trial that is trying to answer this question.
Embed this episode
NOW PLAYING
Clinical Trial Spotlight: Should a Second Generation ALK Inhibitor be First Line Therapy for Patients with ALK-Positive NSCLC?
0:00
4:14
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
GRACEcast Radiation Oncology Video
cancerGRACE - H. Jack West, MD
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
cancerGRACE
In this podcast series, the Global Resource for Advancing Cancer Education (GRACE) works to bring professionals together with patients and caregivers to work in partnership. We interview patients, advocates and healthcare professionals to provide the most updated information for our community and to highlight important issues facing those dealing with a cancer diagnosis. For more information visit www.cancerGRACE.org. To join the conversation, visit https://cancergrace.org/forums
GRACEcast Lung Cancer Audio
cancerGRACE - H. Jack West, MD
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
GRACEcast Lung Cancer Video
cancerGRACE - H. Jack West, MD
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
Frequently Asked Questions
How long is this episode of GRACEcast?
This episode is 4 minutes long.
When was this GRACEcast episode published?
This episode was published on November 14, 2015.
Can I download this GRACEcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!